Immuneonco Biopharmaceuticals (Shanghai) Inc. (Immuneonco Biopharmaceuticals (Shanghai) Inc. (上海)) is an enterprise based in China. Its main office is in Shanghai. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on May 14, 2026. 202 (2025) employees currently work for Immuneonco Biopharmaceuticals (Shanghai) Inc. (Immuneonco Biopharmaceuticals (Shanghai) Inc. (上海)). From the latest financial highlights, Immuneonco Biopharmaceuticals (Shanghai) Inc. (Immuneonco Biopharmaceuticals (Shanghai) Inc. (上海)) reported a net sales revenue increase of 108.09% in 2025. A growth of 19.13% was recorded in its total assets. The net profit margin of Immuneonco Biopharmaceuticals (Shanghai) Inc. (Immuneonco Biopharmaceuticals (Shanghai) Inc. (上海)) increased by 284.84% in 2025.
Headquarters
Unit 15, 1000 Zhangheng Road, China (Shanghai) Pilot Free Trade Zone, Pudong New Area
Shanghai; Shanghai;
Contact Details: Purchase the Immuneonco Biopharmaceuticals (Shanghai) Inc. (Immuneonco Biopharmaceuticals (Shanghai) Inc. (上海)) report to view the information.
Website: http://www.immuneonco.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service